These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling. Ide T; Shimano H; Yoshikawa T; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Yatoh S; Iizuka Y; Tomita S; Ohashi K; Takahashi A; Sone H; Gotoda T; Osuga J; Ishibashi S; Yamada N Mol Endocrinol; 2003 Jul; 17(7):1255-67. PubMed ID: 12730332 [TBL] [Abstract][Full Text] [Related]
3. The liver X receptor modulator 22(S)-hydroxycholesterol exerts cell-type specific effects on lipid and glucose metabolism. Hessvik NP; Bakke SS; Smith R; Ravna AW; Sylte I; Rustan AC; Thoresen GH; Kase ET J Steroid Biochem Mol Biol; 2012 Feb; 128(3-5):154-64. PubMed ID: 22051079 [TBL] [Abstract][Full Text] [Related]
4. Liver X receptor and retinoic X receptor agonists modulate the expression of genes involved in lipid metabolism in human endothelial cells. Norata GD; Ongari M; Uboldi P; Pellegatta F; Catapano AL Int J Mol Med; 2005 Oct; 16(4):717-22. PubMed ID: 16142410 [TBL] [Abstract][Full Text] [Related]
5. Ligand, receptor, and cell type-dependent regulation of ABCA1 and ABCG1 mRNA in prostate cancer epithelial cells. Trasino SE; Kim YS; Wang TT Mol Cancer Ther; 2009 Jul; 8(7):1934-45. PubMed ID: 19531574 [TBL] [Abstract][Full Text] [Related]
6. Liver X receptor antagonist reduces lipid formation and increases glucose metabolism in myotubes from lean, obese and type 2 diabetic individuals. Kase ET; Thoresen GH; Westerlund S; Højlund K; Rustan AC; Gaster M Diabetologia; 2007 Oct; 50(10):2171-80. PubMed ID: 17661008 [TBL] [Abstract][Full Text] [Related]
7. Tissue-specific autoregulation of the LXRalpha gene facilitates induction of apoE in mouse adipose tissue. Ulven SM; Dalen KT; Gustafsson JA; Nebb HI J Lipid Res; 2004 Nov; 45(11):2052-62. PubMed ID: 15292368 [TBL] [Abstract][Full Text] [Related]
8. T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR. Mitro N; Vargas L; Romeo R; Koder A; Saez E FEBS Lett; 2007 May; 581(9):1721-6. PubMed ID: 17418145 [TBL] [Abstract][Full Text] [Related]
9. The influence of ligand-activated LXR on primary human trophoblasts. Larkin JC; Sears SB; Sadovsky Y Placenta; 2014 Nov; 35(11):919-24. PubMed ID: 25255963 [TBL] [Abstract][Full Text] [Related]
10. LXRalpha enhances lipid synthesis in SZ95 sebocytes. Hong I; Lee MH; Na TY; Zouboulis CC; Lee MO J Invest Dermatol; 2008 May; 128(5):1266-72. PubMed ID: 17960176 [TBL] [Abstract][Full Text] [Related]
11. Sulfation of 25-hydroxycholesterol by SULT2B1b decreases cellular lipids via the LXR/SREBP-1c signaling pathway in human aortic endothelial cells. Bai Q; Xu L; Kakiyama G; Runge-Morris MA; Hylemon PB; Yin L; Pandak WM; Ren S Atherosclerosis; 2011 Feb; 214(2):350-6. PubMed ID: 21146170 [TBL] [Abstract][Full Text] [Related]
12. [Activation of liver X receptor regulates fatty acid synthase expression in diabetic liver]. Wang B; Cheng LJ; Gao ZN; Zhang XY; Huo M; Zhang DJ; Wu J; Wei MF Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):848-52. PubMed ID: 18756992 [TBL] [Abstract][Full Text] [Related]
13. 27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. Fu X; Menke JG; Chen Y; Zhou G; MacNaul KL; Wright SD; Sparrow CP; Lund EG J Biol Chem; 2001 Oct; 276(42):38378-87. PubMed ID: 11504730 [TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of peroxisome proliferator activated receptor-gamma and liver X receptor-alpha in the regulation of inflammation in macrophages. Piraino G; Cook JA; O'Connor M; Hake PW; Burroughs TJ; Teti D; Zingarelli B Shock; 2006 Aug; 26(2):146-53. PubMed ID: 16878022 [TBL] [Abstract][Full Text] [Related]
15. 25-Hydroxycholesterol-3-sulfate regulates macrophage lipid metabolism via the LXR/SREBP-1 signaling pathway. Ma Y; Xu L; Rodriguez-Agudo D; Li X; Heuman DM; Hylemon PB; Pandak WM; Ren S Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1369-79. PubMed ID: 18854425 [TBL] [Abstract][Full Text] [Related]
16. Induction of intestinal ATP-binding cassette transporters by a phytosterol-derived liver X receptor agonist. Kaneko E; Matsuda M; Yamada Y; Tachibana Y; Shimomura I; Makishima M J Biol Chem; 2003 Sep; 278(38):36091-8. PubMed ID: 12847102 [TBL] [Abstract][Full Text] [Related]
17. Changes in LXR signaling influence early-pregnancy lipogenesis and protect against dysregulated fetoplacental lipid homeostasis. Nikolova V; Papacleovoulou G; Bellafante E; Borges Manna L; Jansen E; Baron S; Abu-Hayyeh S; Parker M; Williamson C Am J Physiol Endocrinol Metab; 2017 Oct; 313(4):E463-E472. PubMed ID: 28420650 [TBL] [Abstract][Full Text] [Related]
18. The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse. Chisholm JW; Hong J; Mills SA; Lawn RM J Lipid Res; 2003 Nov; 44(11):2039-48. PubMed ID: 12923232 [TBL] [Abstract][Full Text] [Related]
19. Elevated insulin secretion from liver X receptor-activated pancreatic beta-cells involves increased de novo lipid synthesis and triacylglyceride turnover. Green CD; Jump DB; Olson LK Endocrinology; 2009 Jun; 150(6):2637-45. PubMed ID: 19228891 [TBL] [Abstract][Full Text] [Related]
20. The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR. Cha JY; Repa JJ J Biol Chem; 2007 Jan; 282(1):743-51. PubMed ID: 17107947 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]